The head of the committee, Sen. Bernie Sanders, I-Vt., has been vocal about his frustrations over how much Novo Nordisk charges Americans for both Ozempic (used to treat type 2 diabetes) and Wegovy (approved for weight loss).
Mariam Zuhaib / AP“It is clear that Novo Nordisk is ripping off the American people,” Sanders told NBC News in June.
In a statement Monday, Novo Nordisk defended its pricing structure.
Novo Nordisk holds the patent on semaglutide, so other companies aren't able to make a generic version.
That leaves Novo Nordisk — and ultimately Jørgensen — to answer questions about the price of its blockbuster drugs.
Persons:
Lars Fruergaard Jørgensen, Jørgensen, Sen, Bernie Sanders, Sanders, Mariam Zuhaib, ” Sanders, “, United States don’t, ”
Organizations:
Nordisk, Capitol, Health, Education, Labor, Pensions, NBC News, Novo Nordisk, Department of Health, Human Services, NBC, Novo Nordisk —
Locations:
Canada, Europe, United States, Germany, United Kingdom, U.S, Novo